SubscribeElsewhere on HealthThreads: Sleep apnea | Pancreatic cancer | Prostate cancer | Cholesterol | Erectile dysfunction | Asthma | Heart disease | Weight loss | Rheumatoid arthritis |
REVIEW: Efficacy and Safety of Incretin Therapy in Type 2 Diabetes: Systematic Review and Meta-analysis 
Journal of American Medical Association | by Amori, R. E., Lau, J., Pittas, A. G. | Tue, Jul 10
Journal of American Medical Association is the #9 News Source for Diabetes
Study Selection Randomized controlled trials were selected if they were at least 12 weeks in duration, compared incretin therapy with placebo or other diabetes medication, and reported hemoglobin A1c data in nonpregnant adults with type 2 diabetes.
Try These Related Topics
Heart disease
Weight loss
Rheumatoid arthritis
Erectile dysfunction
Pancreatic cancer
Asthma
Sleep apnea
Prostate cancer
Cholesterol
More Journal of American Medical Association
Diet, Exercise Habits, and Risk of Alzheimer Disease—Reply - Journal of American Medical Association
The Need for Large-Scale Randomized Evidence Without Undue Emphasis on Small ... - Journal of American Medical Association
REVIEW: Birth Weight and Risk of Type 2 Diabetes: A Systematic Review
ORIGINAL CONTRIBUTION: Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes
ORIGINAL CONTRIBUTION: Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial
REVIEW: Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus: A Systematic Review and Meta-analysis
ORIGINAL CONTRIBUTION: Effect of a Low-Glycemic Index or a High-Cereal Fiber Diet on Type 2 Diabetes: A Randomized Trial
Related News
Hemoglobin levels predicted proliferative diabetic retinopathy incidence
Design, statistical analysis and sample size calculation of a ... - 7thSpace Interactive
Liraglutide Effect and Action in our Diabetes (LEAD-6)
Pharmacy-led diabetes program saves big
ORIGINAL CONTRIBUTION: Effect of a Low-Glycemic Index or a High-Cereal Fiber Diet on Type 2 Diabetes: A Randomized Trial
Top Bloggers
| 1 | YouTube |
| 2 | Blogcritics |
| 3 | 7thspace.com |
| 4 | ModernMedicine |
| 5 | insidermedicine.com |
| 6 | SDNN |
| 7 | Endocrine Today |
| 8 | diabetes.webmd.com |
| 9 | CMAJ |
| 10 | sev.prnewswire.com |
| 11 | ajcn.org |
| 12 | Read/WriteWeb |
| 13 | wickedlocal.com |
| 14 | WELT ONLINE |
| 15 | HealthJockey.com |
Photo Gallery
Patna doc develops drug to combat diabetes
Good news for diabetics. A Patna doctor has helped develop Liraglutide, a new anti-diabetic drug, which got the approval of the Food and Drug Administration in the US for clinical use on Tuesday.
Wed, Jan 27 | from Times of India
